NIH Weekly Funding Opportunities and Policy Notices

Thursday, March 25, 2021 - 1:07am
Funding Opportunity PAR-21-166 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes.
Thursday, March 25, 2021 - 1:07am
Funding Opportunity PAR-21-206 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes.
Thursday, March 25, 2021 - 12:15am
Funding Opportunity PAR-21-143 from the NIH Guide for Grants and Contracts. The purpose of the NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00) is to support a defined pathway across career stages for talented graduate students from diverse backgrounds, including those from groups underrepresented in biomedical, clinical, behavioral and social sciences. This two-phased award will facilitate completion of a doctoral dissertation (F99) and transition to a strong postdoctoral research position (K00) focused on the scientific, medical, ethical, social and/or legal areas of genomics research. It is anticipated that successful completion of this phased award program will have provided students sufficient scientific and career development activities to set them on the path to becoming independent genomics researchers. This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Wednesday, March 24, 2021 - 11:49pm
Notice NOT-DA-21-028 from the NIH Guide for Grants and Contracts
Wednesday, March 24, 2021 - 8:47am
Notice NOT-AA-21-008 from the NIH Guide for Grants and Contracts
Wednesday, March 24, 2021 - 8:45am
Notice NOT-DA-21-033 from the NIH Guide for Grants and Contracts
Wednesday, March 24, 2021 - 2:55am
Notice NOT-OD-21-080 from the NIH Guide for Grants and Contracts
Tuesday, March 23, 2021 - 10:52am
Notice NOT-TW-21-004 from the NIH Guide for Grants and Contracts
Tuesday, March 23, 2021 - 10:52am
Notice NOT-TW-21-003 from the NIH Guide for Grants and Contracts
Tuesday, March 23, 2021 - 10:47am
Notice NOT-NS-21-041 from the NIH Guide for Grants and Contracts
Tuesday, March 23, 2021 - 10:25am
Notice NOT-OD-21-084 from the NIH Guide for Grants and Contracts
Tuesday, March 23, 2021 - 9:05am
Funding Opportunity RFA-AG-22-009 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to support short courses geared towards advancing selected priority topic areas identified by the National Institute on Aging (NIA) in order to advance research in the behavioral and social sciences. This FOA targets the following three priority research areas: 1) genomics for social scientists; 2) interdisciplinary social science research in aging; and 3) reproducibility in the social and behavioral sciences.
Tuesday, March 23, 2021 - 9:05am
Funding Opportunity RFA-AG-22-010 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to support short courses geared towards advancing selected priority topic areas identified by the National Institute on Aging in order to advance behavioral and social science research on Alzheimer's disease and its related dementias (AD/ADRD). This FOA targets the following three priority research areas: 1) cross-national dementia research using harmonized data on cognitive function; 2) behavioral economic approaches to improve AD/ADRD health care delivery at the organizational level; and 3) integrating machine learning and the social sciences to improve healthcare research in AD/ADRD.
Tuesday, March 23, 2021 - 1:22am
Funding Opportunity RFA-AT-21-006 from the NIH Guide for Grants and Contracts. This proposed initiative aims to solicit applications that focus on developing resources by refining and testing key concepts that will advance and further support the study of the neurocircuitry of force-based manipulations. This grant funding initiative will support research networks through meetings, conferences, small-scale pilot research, multidisciplinary cross training (such as intensive workshops, summer institutes, or visiting scholar programs), and information dissemination to foster the growth and development of research in the specified priority areas listed below.
Tuesday, March 23, 2021 - 12:57am
Funding Opportunity PAR-21-183 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of Digital Therapeutics (DTx) to treat Substance Use Disorders (SUDs). Advances in technology offer unprecedented opportunities to develop clinical-grade mobile, web, or other software-based platforms designed to deliver treatments that are safe and effective for SUD. FDA authorization of DTx can play an important role in increasing the availability of treatments to patients with SUD, although there are other pathways for dissemination of this class of intervention. The primary objective of this FOA is to move DTx to their next step in the development process, with the ultimate goal of generating new, FDA authorized, disseminated treatments for SUDs. Applications may focus on the pre-clinical and/or clinical development and testing of new DTx or existing DTx developed for other indications.
Tuesday, March 23, 2021 - 12:37am
Notice NOT-AI-21-032 from the NIH Guide for Grants and Contracts
Tuesday, March 23, 2021 - 12:36am
Funding Opportunity RFA-MD-21-004 from the NIH Guide for Grants and Contracts. This initiative will support (1) observational research to understand the role of structural racism and discrimination (SRD) in causing and sustaining health disparities, and (2) intervention research that addresses SRD in order to improve minority health or reduce health disparities.

Pages